HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 522 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21 | -19.2% | 177 | -29.5% | 0.00% | – |
| Q2 2023 | $26 | -58.1% | 251 | -55.4% | 0.00% | -100.0% |
| Q1 2023 | $62 | -99.9% | 563 | -99.9% | 0.00% | -99.9% |
| Q4 2022 | $100,067 | -99.8% | 879,328 | -1.1% | 1.02% | +67.2% |
| Q3 2022 | $55,042,000 | -12.7% | 889,352 | +12.5% | 0.61% | -10.7% |
| Q2 2022 | $63,076,000 | -31.5% | 790,818 | -9.7% | 0.68% | -17.2% |
| Q1 2022 | $92,129,000 | +3.1% | 875,673 | +5.6% | 0.82% | +9.9% |
| Q4 2021 | $89,325,000 | +3.6% | 828,925 | +5.4% | 0.75% | -3.0% |
| Q3 2021 | $86,186,000 | +15.7% | 786,796 | -1.1% | 0.77% | +18.8% |
| Q2 2021 | $74,519,000 | +3.4% | 795,807 | +1.6% | 0.65% | -2.4% |
| Q1 2021 | $72,102,000 | +81.0% | 783,371 | +43.8% | 0.66% | +58.9% |
| Q4 2020 | $39,837,000 | +384.2% | 544,585 | +414.2% | 0.42% | +287.0% |
| Q3 2020 | $8,227,000 | -2.4% | 105,915 | -30.2% | 0.11% | -8.5% |
| Q2 2020 | $8,431,000 | +54.4% | 151,696 | -17.7% | 0.12% | +22.9% |
| Q1 2020 | $5,460,000 | -22.5% | 184,329 | -5.3% | 0.10% | +2.1% |
| Q4 2019 | $7,049,000 | – | 194,728 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |